Food and Drug Regulations (C.R.C., c. 870)

Regulations are current to 2014-09-01 and last amended on 2014-08-21. Previous Versions

 The Minister may, on receiving an application made under this Part, require the submission of any additional information that pertains to the information contained in the application and that is necessary for the Minister to process the application.

  • SOR/2004-238, s. 4.

 Subject to section G.02.003.3, the Minister shall, after examining the information and documents required under sections G.02.003 and G.02.003.1, issue a dealer’s licence that contains

  • (a) the licence number;

  • (b) the name of the holder of the licence or the title of the position they hold, as the case may be, or, if the holder is a corporation, its corporate name;

  • (c) a list of the activities that are permitted;

  • (d) the address of the premises at which the licensed dealer may carry on the permitted activities;

  • (e) the name of the controlled drug for which the activities are permitted;

  • (f) the security level at the premises, determined in accordance with the Security Directive;

  • (g) the effective date of the licence;

  • (h) the expiry date of the licence, which may not be later than three years after its effective date;

  • (i) any conditions to be met by the holder of the licence to

    • (i) ensure that an international obligation is respected,

    • (ii) provide the security level referred to in paragraph (f), or

    • (iii) reduce the potential security, public health or safety hazard, including the risk of the controlled drug being diverted to an illicit market or use;

  • (j) in the case of a producer of a controlled drug, the quantity of the controlled drug that may be produced under the licence and the period during which that quantity may be produced; and

  • (k) in the case of the maker or assembler of a product or compound that contains a controlled drug but is not a test kit, an annexed list that sets out the following information for each type of product or compound that may be made or assembled under the licence:

    • (i) the licence number,

    • (ii) the brand name, if any, of each product or compound,

    • (iii) the controlled drug in each product or compound,

    • (iv) the strength per unit of the controlled drug in each product or compound, and

    • (v) the quantity or package sizes of each product or compound.

  • SOR/2004-238, s. 4;
  • SOR/2010-222, ss. 3, 35(F).
  •  (1) The Minister shall refuse to issue, renew or amend a dealer’s licence if

    • (a) the applicant is not an eligible person under section G.02.001.1;

    • (b) an inspector who has requested an inspection has not been given the opportunity by the applicant to conduct an inspection under section G.02.015;

    • (c) false or misleading information or false or falsified documents were submitted in or with the application;

    • (d) an activity for which the licence is requested would not be in compliance with an international obligation;

    • (e) information received from a competent authority or the United Nations raises a reasonable belief that the applicant has been involved in the diversion of a controlled drug to an illicit market or use or has been involved in an activity that was not in compliance with an international obligation;

    • (f) the applicant does not have in place the security measures set out in the Security Directive in respect of an activity for which the licence is requested;

    • (g) the applicant is in contravention of or has contravened during the preceding 10 years

      • (i) a provision of the Act or the regulations made or continued under it, or

      • (ii) a term or condition of another dealer’s licence or of an import or export permit issued to the applicant under any regulations made or continued under the Act;

    • (h) the issuance, amendment or renewal of the licence would likely create a risk to public health, safety or security, including the risk of a controlled drug being diverted to an illicit market or use;

    • (i) the individual in charge of the premises, the proposed qualified person in charge or, if applicable, the alternate proposed qualified person in charge has been convicted, as an adult, within the preceding 10 years, of

      • (i) a designated drug offence,

      • (ii) a designated criminal offence, or

      • (iii) an offence committed outside Canada that, if committed in Canada, would have constituted an offence referred to in subparagraph (i) or (ii);

    • (j) the proposed method referred to in paragraph G.02.003(1)(j) is not capable of recording controlled drug transactions as required under section G.02.014 or permitting the Minister to audit the applicant’s activities with respect to controlled drugs in a timely manner; or

    • (k) the additional information required under section G.02.003.1 has not been provided or is insufficient to process the application.

  • (2) Unless it is necessary to do so to protect public health, safety or security, including preventing a controlled drug from being diverted to an illicit market or use, the Minister shall not refuse to issue, renew or amend a licence under paragraph (1)(c) or (g) if the applicant

    • (a) does not have a history of non compliance with the Act or any regulation made or continued under it; and

    • (b) has carried out, or signed an undertaking to carry out, the necessary corrective measures to ensure compliance with the Act and these Regulations.

  • SOR/2004-238, s. 4;
  • SOR/2010-222, ss. 4, 35(F).